Konakion MM is a medication primarily used for the prevention and treatment of bleeding caused by a deficiency in Vitamin K. Vitamin K is essential for the synthesis of certain proteins required for blood clotting, and a deficiency can lead to increased bleeding risk. Konakion MM, which contains the active ingredient phytomenadione (also known as Vitamin K1), is often administered to newborns to prevent Vitamin K deficiency bleeding (VKDB), a condition that can lead to serious bleeding problems in the first weeks of life. It is also used in adults to treat and prevent bleeding disorders that may arise due to a severe Vitamin K deficiency, which can be caused by various factors including certain medications, diseases affecting absorption in the digestive tract, and prolonged treatment with antibiotics. Konakion MM is available in different forms, including injectable and oral formulations, allowing for flexibility in administration based on the patient's needs and the severity of the deficiency.